Principia Wealth Advisory, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Principia Wealth Advisory, LLC
- $104 Billion
- Q1 2025
A detailed history of Principia Wealth Advisory, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Principia Wealth Advisory, LLC holds 533,778 shares of EYPT stock, worth $3.11 Million. This represents 2.34% of its overall portfolio holdings.
Number of Shares
533,778
Previous 270,382
97.42%
Holding current value
$3.11 Million
Previous $2.01 Billion
21.1%
% of portfolio
2.34%
Previous 1.89%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
157Shares Held
72.7MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$48.5 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$39.5 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$33.5 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$24.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$22.2 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $199M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...